These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20855947)
1. RNAi knockdown of HdmX or Hdm2 leads to new insights into p53 signaling. Berberich SJ Cell Cycle; 2010 Sep; 9(18):3640-1. PubMed ID: 20855947 [No Abstract] [Full Text] [Related]
2. Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53. Heminger K; Markey M; Mpagi M; Berberich SJ Aging (Albany NY); 2009 Jan; 1(1):89-108. PubMed ID: 19946469 [TBL] [Abstract][Full Text] [Related]
3. HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity. Phillips A; Teunisse A; Lam S; Lodder K; Darley M; Emaduddin M; Wolf A; Richter J; de Lange J; Verlaan-de Vries M; Lenos K; Böhnke A; Bartel F; Blaydes JP; Jochemsen AG J Biol Chem; 2010 Sep; 285(38):29111-27. PubMed ID: 20659896 [TBL] [Abstract][Full Text] [Related]
4. Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system. Datta S; Bucks ME; Koley D; Lim PX; Savinov SN Bioorg Med Chem; 2010 Aug; 18(16):6099-108. PubMed ID: 20638853 [TBL] [Abstract][Full Text] [Related]
5. N-acylpolyamine inhibitors of HDM2 and HDMX binding to p53. Hayashi R; Wang D; Hara T; Iera JA; Durell SR; Appella DH Bioorg Med Chem; 2009 Dec; 17(23):7884-93. PubMed ID: 19880322 [TBL] [Abstract][Full Text] [Related]
6. p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction. Medina-Medina I; Martínez-Sánchez M; Hernández-Monge J; Fahraeus R; Muller P; Olivares-Illana V Protein Sci; 2018 May; 27(5):976-986. PubMed ID: 29524278 [TBL] [Abstract][Full Text] [Related]
7. Understanding the interaction of 14-3-3 proteins with hDMX and hDM2: a structural and biophysical study. Srdanović S; Wolter M; Trinh CH; Ottmann C; Warriner SL; Wilson AJ FEBS J; 2022 Sep; 289(17):5341-5358. PubMed ID: 35286747 [TBL] [Abstract][Full Text] [Related]
8. Hdm2 disrupts HdmX-mediated nuclear export of p53 by sequestering it in nucleus. Ni Y; Chen H; Cheng X; Sun B; Wu Z; Zhan Q; Zhuang Z Exp Cell Res; 2024 Aug; 441(2):114185. PubMed ID: 39069150 [TBL] [Abstract][Full Text] [Related]
11. Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmX. Spinnler C; Hedström E; Li H; de Lange J; Nikulenkov F; Teunisse AF; Verlaan-de Vries M; Grinkevich V; Jochemsen AG; Selivanova G Cell Death Differ; 2011 Nov; 18(11):1736-45. PubMed ID: 21546907 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage. Pereg Y; Shkedy D; de Graaf P; Meulmeester E; Edelson-Averbukh M; Salek M; Biton S; Teunisse AF; Lehmann WD; Jochemsen AG; Shiloh Y Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5056-61. PubMed ID: 15788536 [TBL] [Abstract][Full Text] [Related]
13. In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide. Ji Y; Majumder S; Millard M; Borra R; Bi T; Elnagar AY; Neamati N; Shekhtman A; Camarero JA J Am Chem Soc; 2013 Aug; 135(31):11623-11633. PubMed ID: 23848581 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Structural Determinant for Selective Targeting of HDMX. Ben-Nun Y; Seo HS; Harvey EP; Hauseman ZJ; Wales TE; Newman CE; Cathcart AM; Engen JR; Dhe-Paganon S; Walensky LD Structure; 2020 Jul; 28(7):847-857.e5. PubMed ID: 32359398 [TBL] [Abstract][Full Text] [Related]
15. HDM2 and HDMX Proteins in Human Cancer. Hároníková L; Vojtěšek B Klin Onkol; 2018; 31(Suppl 2):63-70. PubMed ID: 31023026 [TBL] [Abstract][Full Text] [Related]
16. Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. Giglio S; Mancini F; Gentiletti F; Sparaco G; Felicioni L; Barassi F; Martella C; Prodosmo A; Iacovelli S; Buttitta F; Farsetti A; Soddu S; Marchetti A; Sacchi A; Pontecorvi A; Moretti F Cancer Res; 2005 Nov; 65(21):9687-94. PubMed ID: 16266988 [TBL] [Abstract][Full Text] [Related]
17. A stapled p53 helix overcomes HDMX-mediated suppression of p53. Bernal F; Wade M; Godes M; Davis TN; Whitehead DG; Kung AL; Wahl GM; Walensky LD Cancer Cell; 2010 Nov; 18(5):411-22. PubMed ID: 21075307 [TBL] [Abstract][Full Text] [Related]
18. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. Lau LM; Nugent JK; Zhao X; Irwin MS Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533 [TBL] [Abstract][Full Text] [Related]
19. Novel simplified yeast-based assays of regulators of p53-MDMX interaction and p53 transcriptional activity. Leão M; Gomes S; Soares J; Bessa C; Maciel C; Ciribilli Y; Pereira C; Inga A; Saraiva L FEBS J; 2013 Dec; 280(24):6498-507. PubMed ID: 24119020 [TBL] [Abstract][Full Text] [Related]
20. Allosteric Interactions by p53 mRNA Govern HDM2 E3 Ubiquitin Ligase Specificity under Different Conditions. Medina-Medina I; García-Beltrán P; de la Mora-de la Mora I; Oria-Hernández J; Millot G; Fahraeus R; Reyes-Vivas H; Sampedro JG; Olivares-Illana V Mol Cell Biol; 2016 Aug; 36(16):2195-205. PubMed ID: 27215386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]